<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Healthcare on FinStatInsight.com</title>
    <link>https://finstatinsight.com/tags/healthcare/</link>
    <description>Recent content in Healthcare on FinStatInsight.com</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Nov 2023 15:01:35 +0300</lastBuildDate><atom:link href="https://finstatinsight.com/tags/healthcare/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Cengild Medical Berhad Q1 2024 Revenue 11% Growth vs Preceding Quarter.</title>
      <link>https://finstatinsight.com/posts/cengild-medical-berhad-q1-2024-revenue-growth-vs-preceding-quarter/</link>
      <pubDate>Thu, 30 Nov 2023 15:01:35 +0300</pubDate>
      
      <guid>https://finstatinsight.com/posts/cengild-medical-berhad-q1-2024-revenue-growth-vs-preceding-quarter/</guid>
      <description>Cengild Medical Berhad Q1-2024 Summary In the current quarter Q1-2024 concluding on September 30, 2023, Cengild Medical Berhad achieved a revenue of RM17.60 million. This marks a notable growth of RM1.83 million, equivalent to 11.62%, when juxtaposed with the preceding quarter concluding on June 30, 2023, which reported revenue of RM15.77 million. The upswing in revenue can be primarily attributed to the heightened volume of patients, leading to an augmentation in both endoscopic procedures and surgeries conducted.</description>
    </item>
    
    <item>
      <title>DC Healthcare Holdings Q3 2023 Financial Loss Due to Higher Administrative Expenses</title>
      <link>https://finstatinsight.com/posts/dc-healthcare-q3-2023-financial-loss-due-to-higher-administrative-expenses/</link>
      <pubDate>Thu, 30 Nov 2023 15:01:35 +0300</pubDate>
      
      <guid>https://finstatinsight.com/posts/dc-healthcare-q3-2023-financial-loss-due-to-higher-administrative-expenses/</guid>
      <description>Q3-2023 Summary Revenue: The Group reported a revenue of RM15.52 million for the current financial quarter, with a significant focus on aesthetic services, contributing approximately 84.28% of the total revenue.
Below is the chart &amp;amp; table showing the segmental analysis of the group&amp;rsquo;s revenue for the past 3 quarters.
Quarters 2023-Q1 2023-Q2 2023-Q3 Items 3/31/2023 6/30/2023 9/30/2023 Aesthetic services 14,930 15,923 13,074 General medical services 1,379 1,432 1,804 Sale of skincare products 502 537 635 Total 16,811 17,892 15,513 Loss Before Tax: Despite the revenue generated, the Group recorded a loss before tax amounting to RM3.</description>
    </item>
    
  </channel>
</rss>
